International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2015, Volume 95, Issue 1, pp. 523 - 533
Purpose The purpose of this study was to compare the impact of uncertainties and interplay on 3-dimensional (3D) and 4D robustly optimized intensity modulated...
Radiology | Hematology, Oncology and Palliative Medicine | Carcinoma, Non-Small-Cell Lung - pathology | Carcinoma, Non-Small-Cell Lung - radiotherapy | Uncertainty | Movement | Area Under Curve | Radiotherapy Planning, Computer-Assisted - methods | Humans | Radiotherapy, Intensity-Modulated - methods | Lung Neoplasms - radiotherapy | Lung Neoplasms - pathology | Organs at Risk | Tumor Burden | Four-Dimensional Computed Tomography | Dose Fractionation | Lung Neoplasms - diagnostic imaging | Carcinoma, Non-Small-Cell Lung - diagnostic imaging | Retrospective Studies | Proton Therapy - methods | Relative Biological Effectiveness | Imaging, Three-Dimensional | Respiration | Care and treatment | Health aspects | Lung cancer | Radiation | Cancer | FRACTIONATION | NEOPLASMS | LUNGS | PLANT TISSUES | PROTON BEAMS | ANIMAL TISSUES | COMPUTERIZED TOMOGRAPHY | GY RANGE 10-100 | RADIATION DOSE DISTRIBUTIONS | RBE | RADIOLOGY AND NUCLEAR MEDICINE | COMPUTER CODES | OPTIMIZATION | RADIOTHERAPY | TIME DEPENDENCE | lung cancer | 4D treatment planning | intensity-modulated proton therapy | interplay effect | respiratory motion | robust optimization
Radiology | Hematology, Oncology and Palliative Medicine | Carcinoma, Non-Small-Cell Lung - pathology | Carcinoma, Non-Small-Cell Lung - radiotherapy | Uncertainty | Movement | Area Under Curve | Radiotherapy Planning, Computer-Assisted - methods | Humans | Radiotherapy, Intensity-Modulated - methods | Lung Neoplasms - radiotherapy | Lung Neoplasms - pathology | Organs at Risk | Tumor Burden | Four-Dimensional Computed Tomography | Dose Fractionation | Lung Neoplasms - diagnostic imaging | Carcinoma, Non-Small-Cell Lung - diagnostic imaging | Retrospective Studies | Proton Therapy - methods | Relative Biological Effectiveness | Imaging, Three-Dimensional | Respiration | Care and treatment | Health aspects | Lung cancer | Radiation | Cancer | FRACTIONATION | NEOPLASMS | LUNGS | PLANT TISSUES | PROTON BEAMS | ANIMAL TISSUES | COMPUTERIZED TOMOGRAPHY | GY RANGE 10-100 | RADIATION DOSE DISTRIBUTIONS | RBE | RADIOLOGY AND NUCLEAR MEDICINE | COMPUTER CODES | OPTIMIZATION | RADIOTHERAPY | TIME DEPENDENCE | lung cancer | 4D treatment planning | intensity-modulated proton therapy | interplay effect | respiratory motion | robust optimization
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 95, Issue 1, pp. 120 - 130
Purpose To provide the foundation for combining immunotherapy to induce tumor antigen–specific T cells with proton radiation therapy to exploit the activity of...
Radiology | Hematology, Oncology and Palliative Medicine | Up-Regulation | Immunotherapy - methods | Prostatic Neoplasms - radiotherapy | Breast Neoplasms - immunology | Chordoma - radiotherapy | Humans | Lung Neoplasms - radiotherapy | Male | Carcinoembryonic Antigen - metabolism | Prostatic Neoplasms - immunology | Neoplasms - therapy | Neoplastic Stem Cells - metabolism | Calreticulin - metabolism | Female | Cell Membrane - metabolism | Cell Membrane - radiation effects | Neoplastic Stem Cells - radiation effects | Radiotherapy Dosage | T-Lymphocytes, Cytotoxic - immunology | Mucin-1 - metabolism | Immunomodulation | HLA Antigens - metabolism | Photons - therapeutic use | Chordoma - immunology | Breast Neoplasms - radiotherapy | Intercellular Adhesion Molecule-1 - metabolism | Lung Neoplasms - immunology | Neoplasms - immunology | Cell Line, Tumor | Combined Modality Therapy - methods | Proton Therapy - methods | Antigens | T cells | Radiotherapy | Immunotherapy | Radiation | Cancer | MAMMARY GLANDS | NEOPLASMS | RADIOLOGY AND NUCLEAR MEDICINE | STEM CELLS | TUMOR CELLS | CARCINOEMBRYONIC ANTIGEN | RADIOSENSITIVITY | RADIOTHERAPY | FLUORINE COMPOUNDS | MODULATION | proton radiation | calreticulin | CTL | immunogenic modulation | cancer stem cells | photon radiation
Radiology | Hematology, Oncology and Palliative Medicine | Up-Regulation | Immunotherapy - methods | Prostatic Neoplasms - radiotherapy | Breast Neoplasms - immunology | Chordoma - radiotherapy | Humans | Lung Neoplasms - radiotherapy | Male | Carcinoembryonic Antigen - metabolism | Prostatic Neoplasms - immunology | Neoplasms - therapy | Neoplastic Stem Cells - metabolism | Calreticulin - metabolism | Female | Cell Membrane - metabolism | Cell Membrane - radiation effects | Neoplastic Stem Cells - radiation effects | Radiotherapy Dosage | T-Lymphocytes, Cytotoxic - immunology | Mucin-1 - metabolism | Immunomodulation | HLA Antigens - metabolism | Photons - therapeutic use | Chordoma - immunology | Breast Neoplasms - radiotherapy | Intercellular Adhesion Molecule-1 - metabolism | Lung Neoplasms - immunology | Neoplasms - immunology | Cell Line, Tumor | Combined Modality Therapy - methods | Proton Therapy - methods | Antigens | T cells | Radiotherapy | Immunotherapy | Radiation | Cancer | MAMMARY GLANDS | NEOPLASMS | RADIOLOGY AND NUCLEAR MEDICINE | STEM CELLS | TUMOR CELLS | CARCINOEMBRYONIC ANTIGEN | RADIOSENSITIVITY | RADIOTHERAPY | FLUORINE COMPOUNDS | MODULATION | proton radiation | calreticulin | CTL | immunogenic modulation | cancer stem cells | photon radiation
Journal Article
3.
Full Text
Clinical Implementation of Intensity Modulated Proton Therapy for Thoracic Malignancies
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 90, Issue 4, pp. 809 - 818
Purpose Intensity modulated proton therapy (IMPT) can improve dose conformality and better spare normal tissue over passive scattering techniques, but range...
Radiology | Hematology, Oncology and Palliative Medicine | CELL LUNG-CANCER | TRIAL | MOTION | ONCOLOGY | SENSITIVITY | STAGE-I | RADIOTHERAPY | TREATMENT UNCERTAINTIES | TUMORS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | RADIATION-THERAPY | ROBUST OPTIMIZATION | Organs at Risk - radiation effects | Uncertainty | Radiotherapy Planning, Computer-Assisted - methods | Humans | Middle Aged | Lung Neoplasms - radiotherapy | Male | Lung - diagnostic imaging | Heart - radiation effects | Aged, 80 and over | Adult | Esophagus - diagnostic imaging | Female | Lung - radiation effects | Esophagus - radiation effects | Radiotherapy Dosage | Movement | Radiotherapy, Intensity-Modulated - methods | Mediastinal Neoplasms - diagnostic imaging | Heart - diagnostic imaging | Four-Dimensional Computed Tomography - methods | Mediastinal Neoplasms - radiotherapy | Organs at Risk - diagnostic imaging | Lung Neoplasms - diagnostic imaging | Aged | Proton Therapy - methods | Care and treatment | Cancer | PATIENTS | NEOPLASMS | QUALITY ASSURANCE | ESOPHAGUS | LUNGS | PROTON BEAMS | RADIATION DOSES | COMPUTERIZED TOMOGRAPHY | PLANNING | HEART | RBE | RADIOLOGY AND NUCLEAR MEDICINE | OPTIMIZATION | SCATTERING
Radiology | Hematology, Oncology and Palliative Medicine | CELL LUNG-CANCER | TRIAL | MOTION | ONCOLOGY | SENSITIVITY | STAGE-I | RADIOTHERAPY | TREATMENT UNCERTAINTIES | TUMORS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | RADIATION-THERAPY | ROBUST OPTIMIZATION | Organs at Risk - radiation effects | Uncertainty | Radiotherapy Planning, Computer-Assisted - methods | Humans | Middle Aged | Lung Neoplasms - radiotherapy | Male | Lung - diagnostic imaging | Heart - radiation effects | Aged, 80 and over | Adult | Esophagus - diagnostic imaging | Female | Lung - radiation effects | Esophagus - radiation effects | Radiotherapy Dosage | Movement | Radiotherapy, Intensity-Modulated - methods | Mediastinal Neoplasms - diagnostic imaging | Heart - diagnostic imaging | Four-Dimensional Computed Tomography - methods | Mediastinal Neoplasms - radiotherapy | Organs at Risk - diagnostic imaging | Lung Neoplasms - diagnostic imaging | Aged | Proton Therapy - methods | Care and treatment | Cancer | PATIENTS | NEOPLASMS | QUALITY ASSURANCE | ESOPHAGUS | LUNGS | PROTON BEAMS | RADIATION DOSES | COMPUTERIZED TOMOGRAPHY | PLANNING | HEART | RBE | RADIOLOGY AND NUCLEAR MEDICINE | OPTIMIZATION | SCATTERING
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 89, Issue 4, pp. 846 - 853
Background We report the first clinical experience and toxicity of multifield optimization (MFO) intensity modulated proton therapy (IMPT) for patients with...
Radiology | Hematology, Oncology and Palliative Medicine | PHOTON | RADIOTHERAPY | ONCOLOGY | CANCER | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | RADIATION-THERAPY | Uncertainty | Follow-Up Studies | Humans | Middle Aged | Proton Therapy - adverse effects | Male | Carcinoma, Squamous Cell - radiotherapy | Chemoradiotherapy | Radiotherapy, Intensity-Modulated - adverse effects | Tongue Neoplasms - drug therapy | Nasopharyngeal Neoplasms - radiotherapy | Adult | Female | Radiotherapy Setup Errors | Nasopharyngeal Neoplasms - drug therapy | Radiotherapy Planning, Computer-Assisted | Tongue Neoplasms - radiotherapy | Radiotherapy Dosage | Carcinoma, Adenoid Cystic - drug therapy | Oropharyngeal Neoplasms - drug therapy | Radiotherapy, Intensity-Modulated - methods | Head and Neck Neoplasms - drug therapy | Oropharyngeal Neoplasms - radiotherapy | Stomatitis - etiology | Quality Assurance, Health Care | Head and Neck Neoplasms - radiotherapy | Pilot Projects | Carcinoma, Squamous Cell - drug therapy | Aged | Carcinoma, Adenoid Cystic - radiotherapy | Proton Therapy - methods | Xerostomia - etiology | Head and neck tumors | Sects | Care and treatment | Nuclear radiation | Index Medicus | HEAD | MEV RANGE 10-100 | PATIENTS | CLINICAL TRIALS | PROTON BEAMS | SKULL | TOXICITY | MEV RANGE 100-1000 | PLANNING | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | OPTIMIZATION | NECK
Radiology | Hematology, Oncology and Palliative Medicine | PHOTON | RADIOTHERAPY | ONCOLOGY | CANCER | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | RADIATION-THERAPY | Uncertainty | Follow-Up Studies | Humans | Middle Aged | Proton Therapy - adverse effects | Male | Carcinoma, Squamous Cell - radiotherapy | Chemoradiotherapy | Radiotherapy, Intensity-Modulated - adverse effects | Tongue Neoplasms - drug therapy | Nasopharyngeal Neoplasms - radiotherapy | Adult | Female | Radiotherapy Setup Errors | Nasopharyngeal Neoplasms - drug therapy | Radiotherapy Planning, Computer-Assisted | Tongue Neoplasms - radiotherapy | Radiotherapy Dosage | Carcinoma, Adenoid Cystic - drug therapy | Oropharyngeal Neoplasms - drug therapy | Radiotherapy, Intensity-Modulated - methods | Head and Neck Neoplasms - drug therapy | Oropharyngeal Neoplasms - radiotherapy | Stomatitis - etiology | Quality Assurance, Health Care | Head and Neck Neoplasms - radiotherapy | Pilot Projects | Carcinoma, Squamous Cell - drug therapy | Aged | Carcinoma, Adenoid Cystic - radiotherapy | Proton Therapy - methods | Xerostomia - etiology | Head and neck tumors | Sects | Care and treatment | Nuclear radiation | Index Medicus | HEAD | MEV RANGE 10-100 | PATIENTS | CLINICAL TRIALS | PROTON BEAMS | SKULL | TOXICITY | MEV RANGE 100-1000 | PLANNING | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | OPTIMIZATION | NECK
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 86, Issue 5, pp. 1007 - 1013
Purpose To evaluate a method for quantifying the effect of setup errors and range uncertainties on dose distribution and dose–volume histogram using...
Radiology | Hematology, Oncology and Palliative Medicine | LUNG-TUMORS | THERAPY | ONCOLOGY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Carcinoma, Non-Small-Cell Lung - radiotherapy | Organs at Risk - radiation effects | Prostatic Neoplasms - radiotherapy | Uncertainty | Radiotherapy Planning, Computer-Assisted - methods | Brain Neoplasms - diagnostic imaging | Humans | Radiation Tolerance | Lung Neoplasms - radiotherapy | Radiotherapy Setup Errors - statistics & numerical data | Spinal Cord - radiation effects | Male | Feasibility Studies | Prostatic Neoplasms - diagnostic imaging | Esophagus - diagnostic imaging | Retrospective Studies | Brain Neoplasms - radiotherapy | Brain Stem - radiation effects | Esophagus - radiation effects | Radiotherapy Dosage | Spinal Cord - diagnostic imaging | Brain Stem - diagnostic imaging | Rectum - radiation effects | Radiography | Rectum - diagnostic imaging | Organs at Risk - diagnostic imaging | Lung Neoplasms - diagnostic imaging | Proton Therapy - statistics & numerical data | Carcinoma, Non-Small-Cell Lung - diagnostic imaging | Proton Therapy - methods | Sects | Nuclear radiation | Analysis | PROSTATE | ERRORS | NEOPLASMS | ESOPHAGUS | RECTUM | LUNGS | PROTON BEAMS | RADIATION DOSES | EXPECTATION VALUE | SIMULATION | PLANNING | SPINAL CORD | RADIATION DOSE DISTRIBUTIONS | RADIOLOGY AND NUCLEAR MEDICINE | BRAIN
Radiology | Hematology, Oncology and Palliative Medicine | LUNG-TUMORS | THERAPY | ONCOLOGY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Carcinoma, Non-Small-Cell Lung - radiotherapy | Organs at Risk - radiation effects | Prostatic Neoplasms - radiotherapy | Uncertainty | Radiotherapy Planning, Computer-Assisted - methods | Brain Neoplasms - diagnostic imaging | Humans | Radiation Tolerance | Lung Neoplasms - radiotherapy | Radiotherapy Setup Errors - statistics & numerical data | Spinal Cord - radiation effects | Male | Feasibility Studies | Prostatic Neoplasms - diagnostic imaging | Esophagus - diagnostic imaging | Retrospective Studies | Brain Neoplasms - radiotherapy | Brain Stem - radiation effects | Esophagus - radiation effects | Radiotherapy Dosage | Spinal Cord - diagnostic imaging | Brain Stem - diagnostic imaging | Rectum - radiation effects | Radiography | Rectum - diagnostic imaging | Organs at Risk - diagnostic imaging | Lung Neoplasms - diagnostic imaging | Proton Therapy - statistics & numerical data | Carcinoma, Non-Small-Cell Lung - diagnostic imaging | Proton Therapy - methods | Sects | Nuclear radiation | Analysis | PROSTATE | ERRORS | NEOPLASMS | ESOPHAGUS | RECTUM | LUNGS | PROTON BEAMS | RADIATION DOSES | EXPECTATION VALUE | SIMULATION | PLANNING | SPINAL CORD | RADIATION DOSE DISTRIBUTIONS | RADIOLOGY AND NUCLEAR MEDICINE | BRAIN
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 87, Issue 5, pp. 946 - 953
Purpose To report quality of life (QOL)/toxicity in men treated with proton beam therapy for localized prostate cancer and to compare outcomes between...
Radiology | Hematology, Oncology and Palliative Medicine | TRIAL | CONFORMAL RADIATION-THERAPY | ONCOLOGY | MEN | RADIOTHERAPY | PHASE I/II | BOOST THERAPY | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PATIENT-REPORTED OUTCOMES | Organs at Risk - radiation effects | Prostatic Neoplasms - pathology | Prostatic Neoplasms - radiotherapy | Prospective Studies | Humans | Intestines - radiation effects | Middle Aged | Proton Therapy - adverse effects | Prostate - radiation effects | Sexuality - radiation effects | Male | Urinary Bladder - radiation effects | Urination Disorders - etiology | Seminal Vesicles - radiation effects | Aged, 80 and over | Quality of Life | Aged | Scattering, Radiation | Proton Therapy - methods | Care and treatment | Nuclear radiation | Health aspects | Prostate cancer | Cancer | Index Medicus | PROSTATE | NEOPLASMS | RADIOLOGY AND NUCLEAR MEDICINE | PROTON BEAMS | TOXICITY | STANDARD OF LIVING | ARGON
Radiology | Hematology, Oncology and Palliative Medicine | TRIAL | CONFORMAL RADIATION-THERAPY | ONCOLOGY | MEN | RADIOTHERAPY | PHASE I/II | BOOST THERAPY | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PATIENT-REPORTED OUTCOMES | Organs at Risk - radiation effects | Prostatic Neoplasms - pathology | Prostatic Neoplasms - radiotherapy | Prospective Studies | Humans | Intestines - radiation effects | Middle Aged | Proton Therapy - adverse effects | Prostate - radiation effects | Sexuality - radiation effects | Male | Urinary Bladder - radiation effects | Urination Disorders - etiology | Seminal Vesicles - radiation effects | Aged, 80 and over | Quality of Life | Aged | Scattering, Radiation | Proton Therapy - methods | Care and treatment | Nuclear radiation | Health aspects | Prostate cancer | Cancer | Index Medicus | PROSTATE | NEOPLASMS | RADIOLOGY AND NUCLEAR MEDICINE | PROTON BEAMS | TOXICITY | STANDARD OF LIVING | ARGON
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 88, Issue 4, pp. 971 - 972
Journal Article
Physics in Medicine and Biology, ISSN 0031-9155, 01/2013, Volume 58, Issue 2, pp. 261 - 273
Volumetric scintillation dosimetry has the potential to provide fast, high-resolution, three-dimensional radiation dosimetry. However, scintillators exhibit a...
SYSTEM | DETECTORS | 3D DOSIMETRY | THERAPY | ENGINEERING, BIOMEDICAL | INTENSITY | LIQUID SCINTILLATOR | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | VERIFICATION | RANGE | Scintillation Counting - methods | Radiometry | Linear Energy Transfer | Proton Therapy - methods | Monte Carlo Method
SYSTEM | DETECTORS | 3D DOSIMETRY | THERAPY | ENGINEERING, BIOMEDICAL | INTENSITY | LIQUID SCINTILLATOR | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | VERIFICATION | RANGE | Scintillation Counting - methods | Radiometry | Linear Energy Transfer | Proton Therapy - methods | Monte Carlo Method
Journal Article
The European Physical Journal C, ISSN 1434-6044, 7/2018, Volume 78, Issue 7, pp. 1 - 18
$$\phi $$ ϕ meson measurements provide insight into strangeness production, which is one of the key observables for the hot medium formed in high-energy...
Nuclear Physics, Heavy Ions, Hadrons | Measurement Science and Instrumentation | Nuclear Energy | Quantum Field Theories, String Theory | Physics | Elementary Particles, Quantum Field Theory | Astronomy, Astrophysics and Cosmology
Nuclear Physics, Heavy Ions, Hadrons | Measurement Science and Instrumentation | Nuclear Energy | Quantum Field Theories, String Theory | Physics | Elementary Particles, Quantum Field Theory | Astronomy, Astrophysics and Cosmology
Journal Article
Geoderma, ISSN 0016-7061, 2009, Volume 152, Issue 3, pp. 338 - 349
Characterization of soil hydraulic properties is an important step for assessing soil water regime in agricultural fields. Because direct measurement of soil...
Saturated hydraulic conductivity | Spectrotransfer functions | Water retention parameters | Pedotransfer functions | VIS–NIR–SWIR | Proximal spectral reflectance | VIS-NIR-SWIR | PLAIN | FIELD | ORGANIC-MATTER | PARAMETERS | WATER-RETENTION | PREDICTION | SOIL SCIENCE | SPECTROSCOPY | CLAY | Soils | Usage | Hydrogeology | Soil moisture | Analysis
Saturated hydraulic conductivity | Spectrotransfer functions | Water retention parameters | Pedotransfer functions | VIS–NIR–SWIR | Proximal spectral reflectance | VIS-NIR-SWIR | PLAIN | FIELD | ORGANIC-MATTER | PARAMETERS | WATER-RETENTION | PREDICTION | SOIL SCIENCE | SPECTROSCOPY | CLAY | Soils | Usage | Hydrogeology | Soil moisture | Analysis
Journal Article
Endocrine Connections, ISSN 2049-3614, 07/2017, Volume 6, Issue 5, pp. 289 - 296
Objective: Autoimmune polyendocrine syndrome type 1 (APS1) is a rare autosomal recessive disorder characterized by progressive organ-specific autoimmunity....
APECED syndrome | Autoimmune regulator gene | Autoimmune polyendocrine syndrome 1 | India | autoimmune regulator gene | POPULATION | TOLERANCE | ANTIINTERFERON AUTOANTIBODIES | CANDIDIASIS | AIRE GENE | REGULATOR | SYNDROME TYPE-I | ENDOCRINOLOGY & METABOLISM | POLYGLANDULAR SYNDROME TYPE-1 | MUTATIONS | autoimmune polyendocrine syndrome 1 | ECTODERMAL DYSTROPHY PATIENTS | Clinical Medicine | Medical and Health Sciences | Endokrinologi och diabetes | Medicin och hälsovetenskap | Klinisk medicin | Endocrinology and Diabetes
APECED syndrome | Autoimmune regulator gene | Autoimmune polyendocrine syndrome 1 | India | autoimmune regulator gene | POPULATION | TOLERANCE | ANTIINTERFERON AUTOANTIBODIES | CANDIDIASIS | AIRE GENE | REGULATOR | SYNDROME TYPE-I | ENDOCRINOLOGY & METABOLISM | POLYGLANDULAR SYNDROME TYPE-1 | MUTATIONS | autoimmune polyendocrine syndrome 1 | ECTODERMAL DYSTROPHY PATIENTS | Clinical Medicine | Medical and Health Sciences | Endokrinologi och diabetes | Medicin och hälsovetenskap | Klinisk medicin | Endocrinology and Diabetes
Journal Article
EUROPEAN PHYSICAL JOURNAL C, ISSN 1434-6044, 03/2018, Volume 78, Issue 3
An invariant differential cross section measurement of inclusive pi(0) and eta meson production atmid-rapidity in pp collisions at root s = 8 TeV was carried...
TRANSVERSE-MOMENTUM | NEUTRAL PION | PB-PB COLLISIONS | SPECTRA | ALICE | PHYSICS, PARTICLES & FIELDS | Physics and Astronomy (miscellaneous) | High Energy Physics | 114 Physical sciences | Nuclear Experiment | Experiment | Engineering (miscellaneous) | Physics and Astronomy (miscellaneous), Relativisti Heavy-Ion Collisions | Physics and Astronomy (miscellaneous); ALICE; LHC
TRANSVERSE-MOMENTUM | NEUTRAL PION | PB-PB COLLISIONS | SPECTRA | ALICE | PHYSICS, PARTICLES & FIELDS | Physics and Astronomy (miscellaneous) | High Energy Physics | 114 Physical sciences | Nuclear Experiment | Experiment | Engineering (miscellaneous) | Physics and Astronomy (miscellaneous), Relativisti Heavy-Ion Collisions | Physics and Astronomy (miscellaneous); ALICE; LHC
Journal Article
European Physical Journal C, ISSN 1434-6044, 08/2018, Volume 78, Issue 8
Neutral pion and η meson invariant differential yields were measured in non-single diffractive p–Pb collisions at √sNN = 5.02 TeV with the ALICE experiment at...
Physics and Astronomy (miscellaneous) | Engineering (miscellaneous) | parton: energy loss | Engineering (miscellaneous); Physics and Astronomy (miscellaneous) | transverse momentum | Astrophysics | meson: inclusive production | 114 Physical sciences | quantum chromodynamics | High Energy Physics - Experiment | High Energy Physics | heavy ion: scattering | Nuclear Experiment | High Energy Physics, Relativistic Heavy-Ion collisions | calorimeter | suppression | [PHYS.NEXP]Physics [physics]/Nuclear Experiment [nucl-ex] | ROOT-S(NN)=5.02 TEV | scaling | meson: production | diffraction | Experiment | Nuclear and particle physics. Atomic energy. Radioactivity | CERN LHC Coll | nucleus nucleus | CERN Lab | p nucleus | [PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex] | Automatic Keywords | p p: scattering | photon: transition | Fysik | Subatomär fysik | Physical Sciences | Subatomic Physics | Naturvetenskap | Natural Sciences
Physics and Astronomy (miscellaneous) | Engineering (miscellaneous) | parton: energy loss | Engineering (miscellaneous); Physics and Astronomy (miscellaneous) | transverse momentum | Astrophysics | meson: inclusive production | 114 Physical sciences | quantum chromodynamics | High Energy Physics - Experiment | High Energy Physics | heavy ion: scattering | Nuclear Experiment | High Energy Physics, Relativistic Heavy-Ion collisions | calorimeter | suppression | [PHYS.NEXP]Physics [physics]/Nuclear Experiment [nucl-ex] | ROOT-S(NN)=5.02 TEV | scaling | meson: production | diffraction | Experiment | Nuclear and particle physics. Atomic energy. Radioactivity | CERN LHC Coll | nucleus nucleus | CERN Lab | p nucleus | [PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex] | Automatic Keywords | p p: scattering | photon: transition | Fysik | Subatomär fysik | Physical Sciences | Subatomic Physics | Naturvetenskap | Natural Sciences
Journal Article
04/2018
Eur. Phys. J. C 78 (2018) 559 $\phi$ meson measurements provide insight into strangeness production, which is one of the key observables for the hot medium...
Journal Article